Atlas Trials

Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients

Clinical trial NCT07637474 · RECRUITING

Trial details

NCT number
NCT07637474
Sponsor
Regina Elena Cancer Institute
Status
RECRUITING
Study type
OBSERVATIONAL
Nsclc
Start date
2024-07-24
Primary completion
2026-07-24
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.